Bank Of New York Mellon Corp Rhythm Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $717,005 - $976,560	32,283 New	32,283 $940,000
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $79,175 - $568,041	18,413 Added 85.66%	39,908 $978,000
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $408,264 - $1.6 Million	-130,854 Reduced 85.89%	21,495 $89,000
Q1 2022 May 11, 2022	SELL	$6.13 - $12.24 $28,007 - $55,924	-4,569 Reduced 2.91%	152,349 $1.76 Million
Q4 2021 Feb 11, 2022	BUY	$8.62 - $13.9 $4,266 - $6,880	495 Added 0.32%	156,918 $1.57 Million
Q3 2021 Nov 12, 2021	BUY	$11.68 - $20.72 $191,446 - $339,621	16,391 Added 11.71%	156,423 $2.04 Million
Q2 2021 Aug 11, 2021	BUY	$18.52 - $22.55 $71,820 - $87,448	3,878 Added 2.85%	140,032 $2.74 Million
Q1 2021 May 13, 2021	BUY	$20.25 - $39.49 $116,073 - $226,356	5,732 Added 4.39%	136,154 $2.9 Million
Q4 2020 Feb 09, 2021	BUY	$21.17 - $32.61 $121,388 - $186,985	5,734 Added 4.6%	130,422 $3.88 Million
Q3 2020 Nov 12, 2020	SELL	$18.13 - $30.61 $29,334 - $49,526	-1,618 Reduced 1.28%	124,688 $2.7 Million
Q2 2020 Aug 12, 2020	BUY	$14.41 - $25.35 $150,959 - $265,566	10,476 Added 9.04%	126,306 $2.82 Million
Q1 2020 May 06, 2020	BUY	$13.16 - $22.9 $77,512 - $134,881	5,890 Added 5.36%	115,830 $1.76 Million
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $478,680 - $625,005	24,510 Added 28.69%	109,940 $2.52 Million
Q3 2019 Nov 07, 2019	SELL	$18.62 - $24.51 $11,711 - $15,416	-629 Reduced 0.73%	85,430 $1.84 Million
Q2 2019 Aug 12, 2019	BUY	$21.11 - $28.48 $348,462 - $470,119	16,507 Added 23.73%	86,059 $1.89 Million
Q1 2019 May 14, 2019	BUY	$24.76 - $31.66 $61,008 - $78,010	2,464 Added 3.67%	69,552 $1.91 Million
Q4 2018 Feb 11, 2019	BUY	$24.11 - $31.34 $164,285 - $213,550	6,814 Added 11.31%	67,088 $1.8 Million
Q3 2018 Nov 09, 2018	BUY	$26.99 - $35.85 $606,762 - $805,943	22,481 Added 59.48%	60,274 $0
Q2 2018 Aug 06, 2018	BUY	$17.02 - $35.2 $229,123 - $473,862	13,462 Added 55.33%	37,793 $1.18 Million
Q1 2018 May 15, 2018	BUY	$19.9 - $32.25 $125,827 - $203,916	6,323 Added 35.11%	24,331 $485,000
Q4 2017 Feb 09, 2018	BUY	$22.0 - $30.51 $396,176 - $549,424	18,008	18,008 $523,000

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

Primecap Management CO Pasadena, CA

7.22M
Shares

$433 Million
0.28% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$405 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

6.4M
Shares

$384 Million
3.59% of portfolio
Ra Capital Management, L.P. Boston, MA

6.08M
Shares

$365 Million
4.44% of portfolio
Goldman Sachs Group Inc New York, NY

3.88M
Shares

$233 Million
0.03% of portfolio

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.34B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account